Phase 1 admin
Ended Awarded
- Contract number
- 75N93022F00060
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755 Part of General Dynamics Corp
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $139,426
Award facts
- Contract value 100% obligated
- $139,426.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award with a potential value of $139,426.00, issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" master IDIQ contract. The award is for a PHASE 1 CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES, with a completion date of December 14, 2022. The contract type is Cost Plus Fixed Fee, and there is no set-aside designation. Dynport Vaccine Company LLC has previously provided preclinical development, clinical trials, diagnostic testing, vaccine stability evaluations, and cGMP production services to support biopharmaceutical products targeting infectious diseases for federal agencies including NIH, HHS, and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
Quick answers
Who was awarded contract 75N93022F00060?
75N93022F00060 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 15, 2021.
How much is contract 75N93022F00060 worth?
The government has obligated $139,426 on 75N93022F00060.
Is contract 75N93022F00060 an order under another contract?
Yes. 75N93022F00060 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract 75N93022F00060 competed?
The extent of competition for 75N93022F00060 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award